TERN
Terns Pharmaceuticals Inc
NASDAQ: TERN · HEALTHCARE · BIOTECHNOLOGY
$52.92
-0.04% today
Updated 2026-04-29
Market cap
$6.11B
P/E ratio
—
P/S ratio
302.64x
EPS (TTM)
$-1.03
Dividend yield
—
52W range
$3 – $53
Volume
6.6M
Terns Pharmaceuticals Inc (TERN) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-14.20%
ROA
-9.91%
Debt/equity
0.00x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2018 | $0.00 | $-17.71M | — | — | — |
| 2019 | $0.00 | $-68.82M | — | — | — |
| 2020 | $0.00 | $-29.35M | — | — | — |
| 2021 | $1.00M | $-50.16M | 100.00% | -4,986.00% | -5,015.80% |
| 2022 | $0.00 | $-60.34M | — | — | — |
| 2023 | $0.00 | $-90.21M | — | — | — |
| 2024 | $0.00 | $-88.85M | — | — | — |
| 2025 | $0.00 | $-96.21M | — | — | — |